ArticleOncotarget2016

Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.

Grazia Graziani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.